Live from the NIH registry
Studies recruiting near Vallejo right now
Top 25 of 1,499 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UCSF Benioff Children's Hospital Oakland — Oakland, California (21.4 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
San Francisco Department of Public Health — San Francisco, California (25.4 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Bass Medical Group ( Site 0123) — Walnut Creek, California (17.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
UCSF Children's Hospital and Research Center at Oakland — Oakland, California (21.4 mi)
· Sponsor: Azafaros B.V.
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
San Francisco — San Francisco, California (25.4 mi)
· Sponsor: Tectonic Operating Company, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Bay Area Retina Associates - Walnut Creek — Walnut Creek, California (17.0 mi)
· Sponsor: Boehringer Ingelheim
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
University of California, San Francisco — San Francisco, California (25.4 mi)
· Sponsor: University of California, San Francisco
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
Tobacco Use Disorder, Substance Use Disorder (SUD)
N/A
Interventional 36 participants sought
San Francisco VA Health Care System — San Francisco, California (25.4 mi)
· Sponsor: University of California, San Francisco
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — San Francisco, California (25.4 mi)
· Sponsor: AstraZeneca
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
Osteoporotic Fractures, Osteoporosis
N/A
Observational 648 participants sought
University of California San Francisco (USCF) Department of Orthopaedic Surgery — San Francisco, California (25.4 mi)
· Sponsor: AO Foundation, AO Spine
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
Heart Diseases, Cardiovascular Disease
N/A
Interventional 110 participants sought
UCSF Medical Center at Parnassus — San Francisco, California (25.4 mi)
· Sponsor: University of California, San Francisco
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — San Francisco, California (25.4 mi)
· Sponsor: Daiichi Sankyo
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
University of California San Francisco UCSF The Madison Clinic for Pediatric Diabetes — San Francisco, California (25.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Meningioma
Phase 1
Interventional 50 participants sought
University of California, San Francisco — San Francisco, California (25.4 mi)
· Sponsor: Javier Villaneuva-Meyer, MD
TBI Rehabilitation and Activation in Veterans
Traumatic Brain Injury
N/A
Interventional 120 participants sought
San Francisco VA Health Care System — San Francisco, California (25.4 mi)
· Sponsor: Northern California Institute of Research and Education
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
University of California, San Francisco — San Francisco, California (25.4 mi)
· Sponsor: GentiBio, Inc
Automated Insulin for Management of Intrapartum Glycemia
Type 1 Diabetes (T1D), Pregnancy
N/A
Interventional 150 participants sought
University of California, San Francisco — San Francisco, California (25.4 mi)
· Sponsor: University of California, San Francisco
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — San Francisco, California (25.4 mi)
· Sponsor: Sameek Roychowdhury
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Thyroid Cancer
Phase 2
Interventional 62 participants sought
University of California, San Francisco — San Francisco, California (25.4 mi)
· Sponsor: Thomas Hope
Sauna for Offline Connections and Interactive, Authentic Living
Loneliness
N/A
Interventional 15 participants sought
Osher Center for Integrative Health — San Francisco, California (25.4 mi)
· Sponsor: University of California, San Francisco
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
UCSF Medical Center at Mission Bay ( Site 0007) — San Francisco, California (25.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
Congenital Diaphragmatic Hernia
N/A
Interventional 10 participants sought
University of California San Francisco Fetal Treatment Center — San Francisco, California (25.4 mi)
· Sponsor: Hanmin Lee
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California (25.4 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
UCSF Helen Diller Medical Center at Parnassus Heights - Neurology — San Francisco, California (25.4 mi)
· Sponsor: Bayer
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
University of California at San Francisco Medical Center/Zuckerberg San Francisco General — San Francisco, California (25.4 mi)
· Sponsor: Magenta Medical Ltd.